Rho-associated kinase is a therapeutic target in neuroblastoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2017-07-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1706011114PMID 28739902PMCID PMC5559038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy

  2017cited by this paper
• Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

  2015cited by this paper
• Insight into planar cell polarity.

  2014cited by this paper
• The genetic landscape of high-risk neuroblastoma

  2013cited by this paper
• Mutationally activated Rho GTPases in cancer

  2013cited by this paper
• Tissue Interactions in Neural Crest Cell Development and Disease

  2013cited by this paper
• Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

  2012cited by this paper
• Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

  2012cited by this paper
• Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

  2012cited by this paper
• Functional stem cell integration assessed by organotypic slice cultures.

  2012cited by this paper
• WNT signalling pathways as therapeutic targets in cancer

  2012cited by this paper
• Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Melanoma genome sequencing reveals frequent PREX2 mutations

  2012cited by this paper
• Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

  2012influential reference
• High genomic instability predicts survival in metastatic high-risk neuroblastoma.

  2012cited by this paper
• Integrative Genomics Viewer

  2011cited by this paper
• Functions of GSK-3 Signaling in Development of the Nervous System

  2011cited by this paper
• Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

  2010cited by this paper
• Recent advances in neuroblastoma.

  2010influential reference
• Rho GTPase function in tumorigenesis.

  2009cited by this paper
• Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

  2009cited by this paper
• The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.

  2009cited by this paper
• Embryonal neural tumours and cell death

  2009cited by this paper
• TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays.

  2009cited by this paper
• The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

  2009cited by this paper
• In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

  2007cited by this paper
• Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

  2006cited by this paper
• BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system.

  2005cited by this paper
• Targeted Disruption of the Mouse Rho-Associated Kinase 2 Gene Results in Intrauterine Growth Retardation and Fetal Death

  2003cited by this paper
• Neuroblastoma: biological insights into a clinical enigma

  2003cited by this paper
• ROCKs: multifunctional kinases in cell behaviour

  2003cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• Targeted expression of MYCN causes neuroblastoma in transgenic mice

  1997cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper

• Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone loss.

  2026cites this paper
• Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapy

  2025cites this paper
• Hyponatraemia and cancer.

  2025cites this paper
• Gene Suppression by siRNA to Induce Apoptosis and Inhibit Tumor Growth on Neuroblastoma Models: A Systematic Review

  2025cites this paper
• Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones

  2024influential citation
• Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as selective ROCK2 inhibitors with anti-breast cancer migration and invasion activities.

  2024cites this paper
• KLF7 promotes neuroblastoma differentiation through the GTPase signaling pathway by upregulating neuroblast differentiation‐associated protein AHNAKs and glycerophosphodiesterase GDPD5

  2024cites this paper
• Reduction of N-Acetylglucosaminyltransferase-I Activity Promotes Neuroblastoma Invasiveness and EGF-Stimulated Proliferation In Vitro

  2024cites this paper
• The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma.

  2024cites this paper
• Rho GTPases signaling mediates aggressiveness and differentiation in neuroblastoma tumors

  2024cites this paper
• The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches

  2024cites this paper
• Unlocking the Potential of Extracellular Vesicles as the Next Generation Therapy: Challenges and Opportunities

  2024cites this paper
• A molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma.

  2023cites this paper
• Extracellular matrix topography drives adrenergic to mesenchymal transition in neuroblastoma

  2023cites this paper
• Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment.

  2023cites this paper
• Potential effects of biomaterials on macrophage function and their signalling pathways.

  2023cites this paper
• Molecular mechanisms of microRNAs in glioblastoma pathogenesis.

  2023cites this paper
• Long non‐coding RNA SNHG11 regulates the Wnt/β‐catenin signaling pathway through rho/ROCK in trabecular meshwork cells

  2023cites this paper
• Hyponatremia and Cancer: From Bedside to Benchside

  2023cites this paper
• AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells

  2023cites this paper
• P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma

  2023cites this paper
• Amoeboid migration in health and disease: Immune responses versus cancer dissemination

  2023cites this paper
• How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers

  2022cites this paper
• Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies

  2022cites this paper
• Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity

  2022cites this paper
• Neural crest cells development and neuroblastoma progression: Role of Wnt signaling

  2022cites this paper
• The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation

  2022cites this paper
• The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells

  2022cites this paper
• The amoeboid state as part of the epithelial-to-mesenchymal transition programme.

  2021cites this paper
• Medulloblastoma drugs in development: Current leads, trials and drawbacks.

  2021cites this paper
• In vivo Functional Genomics for Undiagnosed Patients: The Impact of Small GTPases Signaling Dysregulation at Pan-Embryo Developmental Scale

  2021cites this paper
• From the Matrix to the Nucleus and Back: Mechanobiology in the Light of Health, Pathologies, and Regeneration of Oral Periodontal Tissues

  2021cites this paper
• Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach.

  2021cites this paper
• Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells.

  2021cites this paper
• RhoGTPase Signalling in Cancer Progression and Dissemination.

  2021cites this paper
• Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities

  2021cites this paper
• Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential

  2021cites this paper
• Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension

  2021cites this paper
• Impact of extracellular matrix properties on neuroblastoma genomic heterogeneity

  2020cites this paper
• Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma

  2020cites this paper
• Potentials of miR-15/16 targeting cancer stem cell pathways: Novel implication in cancer chemotherapy

  2020cites this paper
• Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

  2020cites this paper
• Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-ampli ed neuroblastoma cell line

  2020cites this paper
• Should we keep rocking? Portraits from targeting rho kinases in cancer.

  2020cites this paper
• Hormones Secretion and Rho GTPases in Neuroendocrine Tumors

  2020cites this paper
• First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors

  2020cites this paper
• Mechanopharmacology of Rho-kinase antagonism in airway smooth muscle and potential new therapy for asthma.

  2020cites this paper
• Innate and Adaptive Immunity Linked to Recognition of Antigens Shared by Neural Crest-Derived Tumors

  2020cites this paper
• New targeted therapies for malignant neural tumors From systematic discovery to zebrafish models

  2020cites this paper
• Rho-ROCK Signaling in Normal Physiology and as a Key Player in Shaping the Tumor Microenvironment.

  2020cites this paper
• Integrative discovery of treatments for high-risk neuroblastoma

  2020cites this paper
• Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy.

  2019cites this paper
• Neuroblastoma—A Neural Crest Derived Embryonal Malignancy

  2019cites this paper
• Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth

  2019cites this paper
• Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro

  2019cites this paper
• RhoA/ROCK pathway: implication in osteoarthritis and therapeutic targets.

  2019cites this paper
• 6-Substituted purines as ROCK inhibitors with anti-metastatic activity.

  2019cites this paper
• Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors.

  2019cites this paper
• Insulin induces phosphorylation of pyruvate dehydrogenase through RhoA activation pathway in HepG2 cells

  2018cites this paper
• Novel therapeutic targets in pediatric neural tumors

  2018cites this paper
• Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma

  2018cites this paper
• Molecularly Targeted Therapy for Neuroblastoma

  2018cites this paper
• Molecular mechanisms and therapeutic targets in neuroblastoma

  2018cites this paper
• Anticancer agents: Fighting resistance

  2017cites this paper